The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety data from an expanded access program (EAP) of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (MEL).
 
Paul B. Chapman
Honoraria - Bristol-Myers Squibb; Daiichi Sankyo; Genentech/Roche; GlaxoSmithKline; Momenta Pharmaceuticals; Provectus
Consulting or Advisory Role - Bristol-Myers Squibb; Daiichi Sankyo; Genentech/Roche; GlaxoSmithKline; Momenta Pharmaceuticals; Provectus
Research Funding - Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Mario Sznol
Consulting or Advisory Role - Amgen; Anaeropharma; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Immune Design; Kyowa Hakko Kirin; Lion Biotechnologies; Merus; Nektar; Symphony Evolution
Other Relationship - Haymarket Media
 
Christopher Lao
No Relationships to Disclose
 
Rene Gonzalez
Honoraria - Amgen; Bristol-Myers Squibb; Castle Biosciences; GlaxoSmithKline; Roche/Genentech
Consulting or Advisory Role - Piramal Life Science; Roche/Genentech
Research Funding - Bristol-Myers Squibb (Inst); Castle Biosciences (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Roche/Genentech (Inst)
 
Gregory A. Daniels
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Prometheus (Inst); Viralytics (Inst)
 
John A. Thompson
Honoraria - Amgen; Seagen
Consulting or Advisory Role - Amgen; Eisai; Genentech; Seagen
Research Funding - Agensys (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)
 
Ragini Reiney Kudchadkar
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech
Research Funding - Merck
 
William Howard Sharfman
Consulting or Advisory Role - Merck
Research Funding - Bristol-Myers Squibb (Inst)
 
Michael B. Atkins
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Alkermes; Amgen; Bristol-Myers Squibb; C-Cam; Genentech; Genoptix; GlaxoSmithKline; Infinity Pharmaceuticals; Lilly; Merck; Nektar; Novartis; Pfizer; X4 Pharma
 
Anna C. Pavlick
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb
 
Jeffrey R. Infante
No Relationships to Disclose
 
Kevin Kim
Speakers' Bureau - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Jeffrey S. Weber
Stock and Other Ownership Interests - Altor BioScience; Celldex; Merck
Honoraria - Abbvie; Altor BioScience; Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; Daiichi Sankyo; Eisai; Genentech; GlaxoSmithKline; Ichor Medical Systems; Lion Biotechnologies; Merck; Merck; Pieris Pharmaceuticals; Roche
Consulting or Advisory Role - Abbvie; Altor BioScience; Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; Daiichi Sankyo; Eisai; Genentech; GlaxoSmithKline; Ichor Medical Systems; Lion Biotechnologies; Merck; Merck; Pieris Pharmaceuticals; Roche
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Merck (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; Daiichi Sankyo; Genentech; GlaxoSmithKline; Lion Biotechnologies; Merck; Merck; Pieris Pharmaceuticals; Roche
 
Sapna Pradyuman Patel
Consulting or Advisory Role - Amgen; Genentech/Roche; MD Anderson Cancer Center
Speakers' Bureau - Merck
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Prometheus (Inst); Reata Pharmaceuticals (Inst)
 
Suresh Nair
Research Funding - Bristol-Myers Squibb; Celldex
 
C. Lance Cowey
Employment - Texas Oncology
Leadership - McKesson; US Oncology
Stock and Other Ownership Interests - Texas Oncology
Honoraria - Bristol-Myers Squibb; Castle Biosciences; Celgene; Merck; Novartis
Consulting or Advisory Role - Castle Biosciences; Celgene; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Merck
Research Funding - Bristol-Myers Squibb; EMD Serono; Genentech; Merck; Roche
 
Evan J. Lipson
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Castle Biosciences; Merck
Research Funding - Bristol-Myers Squibb
 
Sue Lee
Stock and Other Ownership Interests - Apple; Bristol-Myers Squibb; Merck; Microsoft; Novartis
 
Alexandre Avila
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
F. Stephen Hodi
Consulting or Advisory Role - Amgen; Genentech/Roche; Merck Sharp & Dohme; Novartis
Research Funding - bristol-myers squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); novartis (Inst)
Patents, Royalties, Other Intellectual Property - patent pending as per institutional policy; patent pending royalties received on MICA related disorders application to institution per institutional IP policy
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
Other Relationship - Bristol-Myers Squibb; Genentech/Roche